89 related articles for article (PubMed ID: 6275988)
1. Phase II study of procarbazine in small cell carcinoma of the lung.
Pedersen AG; Sörenson S; Aabo K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1982 Feb; 66(2):273-5. PubMed ID: 6275988
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lung.
Sörenson S; Hansen HH; Dombernowsky P
Cancer Treat Rep; 1976 Sep; 60(9):1263-6. PubMed ID: 189921
[TBL] [Abstract][Full Text] [Related]
3. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma.
Cohen MH; Broder LE; Fossieck BE; Bull M; Ihde DC; Minna JD
Cancer Treat Rep; 1977; 61(3):485-7. PubMed ID: 194693
[No Abstract] [Full Text] [Related]
5. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
[No Abstract] [Full Text] [Related]
6. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
[No Abstract] [Full Text] [Related]
7. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
8. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of vinblastine in small cell carcinoma of the lung.
Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
Bunn PA; Kelly KL
Semin Oncol; 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PubMed ID: 7481862
[TBL] [Abstract][Full Text] [Related]
12. Taxol in the treatment of lung cancer.
Ettinger DS
J Natl Cancer Inst Monogr; 1993; (15):177-9. PubMed ID: 7912523
[TBL] [Abstract][Full Text] [Related]
13. Vincristine (NSC-67574) in the treatment of small-cell anaplastic carcinoma of the lung.
Dombernowsky P; Hansen HH; Sorensen PG; Hainau B
Cancer Treat Rep; 1976 Mar; 60(3):239-42. PubMed ID: 177209
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
15. [Polychemotherapy of small-cell lung cancer].
Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
[No Abstract] [Full Text] [Related]
16. [Effects of oral etoposide in small cell carcinoma of the lung].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
[TBL] [Abstract][Full Text] [Related]
20. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
